Shareholders' Equity - Share capital (Details) - EUR (€) € / shares in Units, € in Thousands |
1 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2022 |
Sep. 30, 2021 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Shareholders Equity | ||||
| Authorized share capital | € 21,600 | |||
| Par value per share | € 0.04 | |||
| Shares issued in the period | € 49,201 | |||
| Eli Lilly and Company | ||||
| Shareholders Equity | ||||
| Issue of ordinary shares (in shares) | 9,381,586 | 3,989,976 | ||
| Ordinary | ||||
| Shareholders Equity | ||||
| Number of shares authorised | 270,000,000 | |||
| Number of shares issued | 143,466,309 | |||
| Number of shares issued and fully paid | 141,121,476 | |||
| Treasury shares | 2,344,833 | 2,349,852 | ||
| Preferred | ||||
| Shareholders Equity | ||||
| Number of shares authorised | 270,000,000 | |||
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The increase in equity through the issue of equity instruments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares authorised. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares issued by the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares issued by the entity, for which full payment has been received. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The nominal value per share. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Total for all associates [member]; Total for all subsidiaries [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of authorized share capital value. No definition available.
|
| X | ||||||||||
- Definition Number of new stock shares issued during the period. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|